APA (7th ed.) Citation

Reuter, N., Chen, X., Kropff, B., Peter, A. S., Britt, W. J., Mach, M., . . . Thomas, M. (2023). SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies. Friedrich-Alexander-Universität Erlangen-Nürnberg.

Chicago Style (17th ed.) Citation

Reuter, Nina, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla, and Marco Thomas. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023.

MLA (9th ed.) Citation

Reuter, Nina, et al. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023.